相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H
Jia-Xiong Kang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
HIV-1 3′-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR Circles
Jose G. Dekker et al.
JOURNAL OF VIROLOGY (2023)
Mutations in the HIV-1 3′-Polypurine Tract Can Confer Dolutegravir Resistance
Jose G. Dekker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase
Kathleen M. Frey et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Novel RNase H Inhibitors Blocking RNA-directed Strand Displacement DNA Synthesis by HIV-1 Reverse Transcriptase
Samara Martin-Alonso et al.
JOURNAL OF MOLECULAR BIOLOGY (2022)
Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors
Lina Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration
Clemence Richetta et al.
JOURNAL OF VIROLOGY (2022)
Close-up: HIV/SIV intasome structures shed new light on integrase inhibitor binding and viral escape mechanisms
Alan N. Engelman et al.
FEBS JOURNAL (2021)
Exploring New Scaffolds for the Dual Inhibition of HIV-1 RT Polymerase and Ribonuclease Associated Functions
Rita Meleddu et al.
MOLECULES (2021)
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase-associated RNase H function
Benedetta Fois et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors
Francesca Esposito et al.
ANTIVIRAL RESEARCH (2020)
Targeting HIV-1 RNase H:N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants
Angela Corona et al.
VIRUSES-BASEL (2020)
New targets for HIV drug discovery
Ana C. Puhl et al.
DRUG DISCOVERY TODAY (2019)
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity
Francesca Esposito et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase
Paul L. Boyer et al.
JOURNAL OF VIROLOGY (2018)
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
Ravindra K. Gupta et al.
LANCET INFECTIOUS DISEASES (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase
Rita Meleddu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase
Vijay P. Sonar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome
Dario Oliveira Passos et al.
SCIENCE (2017)
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding
Riccardo Martini et al.
CHEMBIOCHEM (2017)
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H
Angela Corona et al.
ANTIVIRAL RESEARCH (2016)
HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently
An Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6
Angela Corona et al.
PLOS ONE (2016)
Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation
Francesca Esposito et al.
CHEMBIOCHEM (2015)
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase
Rita Meleddu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance
Isabelle Malet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration
Sylvain Thierry et al.
RETROVIROLOGY (2015)
Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives
Angela Corona et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Design, Synthesis, and Biological Evaluation of 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 Reverse Transcriptase
Rita Meleddu et al.
CHEMMEDCHEM (2014)
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006-2014)
Jonas Demeulemeester et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development?
Angela Corona et al.
FUTURE VIROLOGY (2014)
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors
Simona Distinto et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
Soundasse Munir et al.
RETROVIROLOGY (2013)
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach
Simona Distinto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Targets for Inhibition of HIV Replication: Entry, Enzyme Action, Release and Maturation
Saleta Sierra-Aragon et al.
INTERVIROLOGY (2012)
Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Jacques J. Kessl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Crystal Structure of tert-Butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in Complex with HIV-1 Reverse Transcriptase (RT) Redefines the Elastic Limits of the Non-nucleoside Inhibitor-Binding Pocket
Kalyan Das et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC
Caroline A. Davis et al.
VIROLOGY (2011)
Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors
Martin Sippel et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex
Manuel Tsiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
Stefan G. Sarafianos et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Jacques J. Kessl et al.
MOLECULAR PHARMACOLOGY (2009)
Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site
Daniel M. Himmel et al.
STRUCTURE (2009)
Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase
Li Du et al.
ACTA PHARMACOLOGICA SINICA (2008)
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
David A. Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
Kalyan Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
JD Pata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry
N Shkriabai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations in the ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding
JV Cristofaro et al.
BIOCHEMISTRY (2002)
Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo
JG Julias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding
JS Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
